VERTEX PHARMACEUTICALS INCORPORATED

MarketScreener Strategies Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 10/07/2025 BST			5-day change	1st Jan Change
479.53 ^USD	+0.12%		+4.92%	+19.08%

07-07	RBC Raises Price Target on Vertex Pharmaceuticals to $430 From $420, Keeps Sector Perform Rating	MT
07-03	Vertex Says Long-Term Data Show Casgevy's 'Durable' Clinical Benefits in Blood Disorder Trials	MT

MarketScreener Strategies

	Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease	December 11, 2023 at 10:47 am
	Vertex Pharmaceuticals Incorporated : Confirms growth trajectory	May 04, 2023 at 02:35 pm
	Vertex Pharmaceuticals : A very promising pipeline	January 11, 2023 at 10:20 am

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease

Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease

December 11, 2023 at 10:47 am

Stock Market
Equities
VRTX Stock
News Vertex Pharmaceuticals Incorporated
MarketScreener Strategies

All our actual portfolios continue to outperform their benchmark.

Discover our performance

Discover our performance